Literature DB >> 25830811

Risk of Suicide Following Deliberate Self-poisoning.

Yaron Finkelstein1, Erin M Macdonald2, Simon Hollands2, Marco L A Sivilotti3, Janine R Hutson4, Muhammad M Mamdani5, Gideon Koren6, David N Juurlink7.   

Abstract

IMPORTANCE: Suicide is the tenth leading cause of death in the United States, and its rate has risen by 16% in the past decade. Deliberate self-poisoning is the leading method of attempted suicide. Unlike more violent methods, which are almost universally fatal, survival following self-poisoning is common, providing an opportunity for secondary prevention. However, the long-term risk of suicide following a first episode of self-poisoning is unknown.
OBJECTIVE: To determine the risk of suicide and mortality from other causes following a first self-poisoning episode. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study using multiple linked health care databases. We identified all individuals with a first self-poisoning episode in Ontario, Canada, from April 1, 2002, through December 31, 2010, and followed up all surviving participants until December 31, 2011, or death, whichever occurred first. For each individual with a deliberate self-poisoning episode, we randomly selected 1 control from the same population with no such history, matched for age (within 3 months), sex, and calendar year. MAIN OUTCOMES AND MEASURES: The primary analysis examined the risk of suicide following discharge after self-poisoning. The secondary analyses explored factors associated with suicide and examined the risk of death caused by accidents or any other cause.
RESULTS: We identified 65 784 patients (18 482 [28.1%] younger than 20 years) who were discharged after a first self-poisoning episode. During a median follow-up of 5.3 years (interquartile range, 3.1-7.6 years), 4176 died, including 976 (23.4%) by suicide. The risk of suicide following self-poisoning was markedly increased relative to controls (hazard ratio, 41.96; 95% CI, 27.75-63.44), corresponding to a suicide rate of 278 vs 7 per 100 000 person-years, respectively. The median time from hospital discharge to completed suicide was 585 days (interquartile range, 147-1301 days). Older age, male sex, multiple intervening self-poisoning episodes, higher socioeconomic status, depression, and recent psychiatric care were strongly associated with suicide. Patients with a self-poisoning episode were also more likely to die because of accidents (hazard ratio, 10.45; 95% CI, 8.10-13.47) and all causes combined (hazard ratio, 5.55; 95% CI, 5.12-6.02). CONCLUSIONS AND RELEVANCE: A first self-poisoning episode is a strong predictor of subsequent suicide and premature death. Most suicides occur long after the index poisoning, emphasizing the importance of longitudinal, sustained secondary prevention initiatives.

Entities:  

Mesh:

Year:  2015        PMID: 25830811     DOI: 10.1001/jamapsychiatry.2014.3188

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  41 in total

1.  Association between suicide death and concordance with benzodiazepine treatment guidelines for anxiety and sleep disorders.

Authors:  Jennifer M Boggs; Richard C Lindrooth; Catherine Battaglia; Arne Beck; Debra P Ritzwoller; Brian K Ahmedani; Rebecca C Rossom; Frances L Lynch; Christine Y Lu; Beth E Waitzfelder; Ashli A Owen-Smith; Gregory E Simon; Heather D Anderson
Journal:  Gen Hosp Psychiatry       Date:  2019-11-17       Impact factor: 3.238

2.  National study of emergency department disposition for high suicide risk geriatric patients.

Authors:  Timothy Schmutte; Mark Olfson; Ming Xie; Steven C Marcus
Journal:  Gen Hosp Psychiatry       Date:  2019-03-27       Impact factor: 3.238

Review 3.  Recent Advances in Means Safety as a Suicide Prevention Strategy.

Authors:  Hyejin M Jin; Lauren R Khazem; Michael D Anestis
Journal:  Curr Psychiatry Rep       Date:  2016-10       Impact factor: 5.285

4.  Community pharmacists' attitudes on suicide: A preliminary analysis with implications for medical assistance in dying.

Authors:  Andrea L Murphy; Claire O'Reilly; Ruth Martin-Misener; Randa Ataya; David Gardner
Journal:  Can Pharm J (Ott)       Date:  2017-12-01

5.  Premature Death Among Primary Care Patients With a History of Self-Harm.

Authors:  Matthew J Carr; Darren M Ashcroft; Evangelos Kontopantelis; David While; Yvonne Awenat; Jayne Cooper; Carolyn Chew-Graham; Nav Kapur; Roger T Webb
Journal:  Ann Fam Med       Date:  2017-05       Impact factor: 5.166

6.  Predicting 3-month risk for adolescent suicide attempts among pediatric emergency department patients.

Authors:  Cheryl A King; Jacqueline Grupp-Phelan; David Brent; J Michael Dean; Michael Webb; Jeffrey A Bridge; Anthony Spirito; Lauren S Chernick; E Melinda Mahabee-Gittens; Rakesh D Mistry; Margaret Rea; Allison Keller; Alexander Rogers; Rohit Shenoi; Mary Cwik; Danielle R Busby; T Charles Casper
Journal:  J Child Psychol Psychiatry       Date:  2019-07-21       Impact factor: 8.982

7.  Risk of suicide after a concussion.

Authors:  Michael Fralick; Deva Thiruchelvam; Homer C Tien; Donald A Redelmeier
Journal:  CMAJ       Date:  2016-02-08       Impact factor: 8.262

8.  Suicide Attempt as a Risk Factor for Completed Suicide: Even More Lethal Than We Knew.

Authors:  J Michael Bostwick; Chaitanya Pabbati; Jennifer R Geske; Alastair J McKean
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

9.  Community pharmacists' experiences and people at risk of suicide in Canada and Australia: a thematic analysis.

Authors:  Andrea L Murphy; Randa Ataya; Dani Himmelman; Claire O'Reilly; Alan Rosen; Luis Salvador-Carulla; Ruth Martin-Misener; Fred Burge; Stanley Kutcher; David M Gardner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2018-06-23       Impact factor: 4.328

Review 10.  A scoping review of community pharmacists and patients at risk of suicide.

Authors:  Andrea Lynn Murphy; Katelyn Hillier; Randa Ataya; Pierre Thabet; Anne Marie Whelan; Claire O'Reilly; David Gardner
Journal:  Can Pharm J (Ott)       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.